These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31623141)

  • 1. Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank.
    Krauss E; Haberer J; Maurer O; Barreto G; Drakopanagiotakis F; Degen M; Seeger W; Guenther A
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31623141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of breathprints of lung cancer and chronic obstructive pulmonary disease using the Aeonose
    Krauss E; Haberer J; Barreto G; Degen M; Seeger W; Guenther A
    J Breath Res; 2020 Jul; 14(4):046004. PubMed ID: 32325432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.
    Plantier L; Smolinska A; Fijten R; Flamant M; Dallinga J; Mercadier JJ; Pachen D; d'Ortho MP; van Schooten FJ; Crestani B; Boots AW
    Respir Res; 2022 Jan; 23(1):12. PubMed ID: 35057817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease.
    Moor CC; Oppenheimer JC; Nakshbandi G; Aerts JGJV; Brinkman P; Maitland-van der Zee AH; Wijsenbeek MS
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhalative Breath Markers Do Not Offer for Diagnosis of Interstitial Lung Diseases: Data from the European IPF Registry (eurIPFreg) and Biobank.
    Krauss E; Froehler M; Degen M; Mahavadi P; Dartsch RC; Korfei M; Ruppert C; Seeger W; Guenther A
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31075945
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
    van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
    Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.
    Cameli P; Bargagli E; Bergantini L; Refini RM; Pieroni M; Sestini P; Rottoli P
    J Breath Res; 2019 Mar; 13(2):026008. PubMed ID: 30690441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Electronic Nose Technology in Sarcoidosis.
    van der Sar IG; Moor CC; Oppenheimer JC; Luijendijk ML; van Daele PLA; Maitland-van der Zee AH; Brinkman P; Wijsenbeek MS
    Chest; 2022 Mar; 161(3):738-747. PubMed ID: 34756945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interstitial lung disease spectrum under a uniform diagnostic algorithm: a retrospective study of 1,945 individuals.
    Guo B; Wang L; Xia S; Mao M; Qian W; Peng X; Zheng Z; Chen R; Han Q; Luo Q
    J Thorac Dis; 2020 Jul; 12(7):3688-3696. PubMed ID: 32802448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nailfold capillaroscopy in interstitial lung diseases - can it differentiate idiopathic cases from collagen tissue disease associated interstitial lung diseases?
    Çakmakçı Karadoğan D; Balkarlı A; Önal Ö; Altınışık G; Çobankara V
    Tuberk Toraks; 2015; 63(1):22-30. PubMed ID: 25849052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
    Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
    Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study.
    Siebert JN; Hartley MA; Courvoisier DS; Salamin M; Robotham L; Doenz J; Barazzone-Argiroffo C; Gervaix A; Bridevaux PO
    BMC Pulm Med; 2023 Jun; 23(1):191. PubMed ID: 37264374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases.
    Bergantini L; d'Alessandro M; Cameli P; Perrone A; Cekorja B; Boncompagni B; Mazzei MA; Sestini P; Bargagli E
    Eur J Intern Med; 2021 Jul; 89():76-80. PubMed ID: 33931268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
    Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
    Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
    Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.